ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Final Issue of ‘76

December 10, 1976

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975